Medical Education Grants
Medical Education Grants
Alkermes supports continuing medical education with grants for educational activities focused on pragmatic approaches to improving patient care and public health. We hope to contribute to an improved understanding of the underlying mechanisms of the diseases we research and their relevance to medications, as well as psychosocial interventions.
Grant funding may be available for activities, including live, print, enduring or web-based continuing medical education (CME) activities. Accredited CME activities are preferred.
Alkermes is currently accepting grant proposals related to:
- Schizophrenia
- Bipolar Disorder
- Narcolepsy
- Idiopathic Hypersomnia
Schizophrenia and Bipolar Disorder Learners of interest:
- Nurse Practitioners
- Psychiatrists
- Primary Care Providers
- Physician Assistants
- Social Workers
- Pharmacists
Narcolepsy and Idiopathic Hypersomnia Learners of interest:
- Sleep Medicine Specialists
- Neurologists
- Psychiatrists
- Pulmonologists
- Pediatricians
- Nurse Practitioners
- Primary Care Providers
For all questions, please contact: Med.Ed@alkermes.com
Who May Apply
Only organizations based in the U.S. may apply. Medical education grants may be awarded to (i) nonprofit organizations with tax exempt status under the U.S. Internal Revenue Code or (ii) for-profit organizations that are accredited continuing medical education providers.
How to Apply
Requests must be submitted online by the educational provider. Submissions are due at least 90 days in advance of the activity date.
Areas of Interest
Alkermes is currently accepting proposals that address the topic areas listed below for Schizophrenia, Bipolar Disorder, Narcolepsy, and Idiopathic Hypersomnia
Schizophrenia
- Understanding patient-centered approaches to address one or more of the following challenges in the care of patients with schizophrenia:
- Practical training in long-acting injectable (LAI) administration
- Optimizing patient treatment across stages of illness, including side effects and polypharmacy considerations
- Long term medication adherence strategies for long acting injectables
- Consideration of co-occurring disorders in treatment planning
Bipolar Disorder
- Understanding patient-centered approaches to address one or more of the following challenges in the care of patients with bipolar disorder:
- Optimizing patient treatment across stages of illness, including side effects and polypharmacy considerations
- Treatment of mixed states
- Long term medication adherence strategies for oral medications
- Consideration of co-occurring disorders in treatment planning
Narcolepsy and Idiopathic Hypersomnia
- Understanding the pathophysiology of, and the role of orexin neuropeptides in, Excessive Daytime Sleepiness (EDS), Narcolepsy and/or Idiopathic Hypersomnia
- Clinical Strategies to improve earlier screening and diagnosis of patients with Narcolepsy and/or Idiopathic Hypersomnia
- Elucidate the complexity of narcolepsy and/or Idiopathic Hypersomnia patients and their predisposed neurological, psychiatric, metabolic, endocrine, hepatic and GI co-morbidities
